Man Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-135,546
| Closed | -$508K | – | 2011 |
|
|
2021
Q4 | $508K | Sell |
135,546
-12,759
| -9% | -$47.8K | ﹤0.01% | 1514 |
|
|
2021
Q3 | $767K | Buy |
148,305
+45,437
| +44% | +$235K | ﹤0.01% | 1414 |
|
|
2021
Q2 | $438K | Sell |
102,868
-32,344
| -24% | -$138K | ﹤0.01% | 1595 |
|
|
2021
Q1 | $718K | Buy |
135,212
+31,740
| +31% | +$169K | ﹤0.01% | 1383 |
|
|
2020
Q4 | $558K | Buy |
103,472
+29,819
| +40% | +$161K | ﹤0.01% | 1523 |
|
|
2020
Q3 | $588K | Buy |
73,653
+36,498
| +98% | +$291K | ﹤0.01% | 1511 |
|
|
2020
Q2 | $372K | Buy |
37,155
+3,333
| +10% | +$33.4K | ﹤0.01% | 1509 |
|
|
2020
Q1 | $92K | Sell |
33,822
-1,050,981
| -97% | -$2.86M | ﹤0.01% | 1510 |
|
|
2019
Q4 | $1.3M | Sell |
1,084,803
-964,865
| -47% | -$1.16M | ﹤0.01% | 1437 |
|
|
2019
Q3 | $3.1M | Buy |
2,049,668
+210,443
| +11% | +$318K | 0.01% | 1086 |
|
|
2019
Q2 | $7.39M | Buy |
1,839,225
+500,595
| +37% | +$2.01M | 0.03% | 771 |
|
|
2019
Q1 | $5.76M | Buy |
1,338,630
+294,619
| +28% | +$1.27M | 0.02% | 835 |
|
|
2018
Q4 | $6M | Buy |
1,044,011
+645,109
| +162% | +$3.71M | 0.03% | 674 |
|
|
2018
Q3 | $5.41M | Buy |
+398,902
| New | +$5.41M | 0.02% | 936 |
|